[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100557670":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":10,"centralContacts":28,"locations":34,"responsibleParty":52,"collaborators":10,"id":55,"slug":10,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":10,"eligibilityCriteria":60,"healthyVolunteers":61,"sex":62,"minAge":63,"maxAge":64,"enrollmentInfo":65,"targetDuration":10,"studyType":68,"phases":10,"briefSummary":69,"conditions":70,"keywords":75,"overallStatus":37,"whyStopped":10,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Chongqing Medical University","OTHER",[8,12,17,20],{"label":9,"type":10,"description":11,"interventionNames":10},"Non-CAD group",null,"non-coronary artery disease group",{"label":13,"type":10,"description":14,"interventionNames":15},"CAD group","coronary artery disease group",[16],"Other: Observational study without human intervention",{"label":18,"type":10,"description":19,"interventionNames":10},"SS≤22 group","SYNTAX score ≤22",{"label":21,"type":10,"description":22,"interventionNames":23},"SS≥23 group","SYNTAX score ≥23",[16],[25],{"type":6,"name":26,"description":26,"armGroupLabels":27,"otherNames":10},"Observational study without human intervention",[13,21],[29],{"name":30,"role":31,"phone":32,"phoneExt":10,"email":33},"Tingqiu Wang","CONTACT","+8617815370539","w857683014@163.com",[35],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"The Second Affiliated Hospital of Chongqing Medical University","RECRUITING","Chongqing","Chongqing Municipality","400000","China",{"type":43,"coordinates":44},"Point",[45,46],106.55771,29.56026,{"lat":46,"lon":45},[49],{"name":50,"role":31,"phone":51,"phoneExt":10,"email":33},"Tingqiu Wang, Bachelor","17815370539",{"type":53,"investigatorFullName":30,"investigatorTitle":54,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Principal Investigator","100557670",false,"NCT06541132","Positive Association of US-FLI With the Severity of CAD","Positive Association Between Ultrasonographic Fatty Liver Indicator and the Severity of Coronary Artery Disease","Inclusion Criteria:\n\n* Patients older than 18 years old\n* Patients underwent ICA due to chest pain, chest tightness or other reasons in our hospital from August 2022 to December 2023 were included in our study\n\nExclusion Criteria:\n\n* Incomplete clinical data\n* previous coronary stent implantation\n* no abdominal ultrasound examination\n* poor ultrasound image quality\n* congenital heart disease\n* tumor\n* thyroid diseases and infectious diseases",true,"ALL","18 Years","90 Years",{"count":66,"type":67},190,"ESTIMATED","OBSERVATIONAL","As a multisystem disease, metabolic dysfunction-associated fatty liver disease (MAFLD) is closely linked to the onset and progression of coronary heart disease (CHD). Ultrasonographic fatty liver indicator (US-FLI) is a semi-quantitative tool for evaluating the degree of hepatic steatosis. Our study aims to explore the relationship between US-FLI based on MAFLD and the severity of CHD.",[71,72,73,74],"Coronary Artery Disease of Significant Bypass Graft","Metabolic Dysfunction-associated Fatty Liver Disease","SYNTAX Score","Ultrasonography",[76,72,77,74],"Coronary Artery Disease","SYNTAX score","2024-08-19",{"date":80,"type":81},"2024-08-21","ACTUAL",{"date":83,"type":81},"2022-07-01",{"date":85,"type":67},"2025-04-28",{"name":5,"class":6},1]